AC8
Click for more information
0.00% 4.0¢ auscann group holdings ltd

Ann: Auscann - Tasmanian Alkaloids Licences Secured, page-11

  1. bardz18
    20 Posts.
    lightbulb Created with Sketch. 1
    clock Created with Sketch.
    11/07/17
    09:35
    Post #: 25783743
    I am a holder of AC8 (got in very early) and ZLD ( both stocks are cousins imo) and am also very excited about this announcement.
    But.... this licence is R&D and I quote from their announcement below, does this mean that they can actually sell this product at either a wholesale or retail level or is it just R&D?

    • Australian medicinal cannabis licence, and a research and development licence, granted to AusCann’s strategic partner Tasmanian Alkaloids

    AC8 Price at posting: 42.5¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

HVN Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24
right-arrow Created with Sketch.
NEWS Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch
right-arrow Created with Sketch.
NEWS Results wrap: Wesfarmers, Southern Cross Media, Qantas
right-arrow Created with Sketch.
NEWS Government spend has to stop or interest rates must rise, property expert
right-arrow Created with Sketch.
HYT Twiggy Forrest to acquire 40% of native hydrogen explorer – not long after putting Fortescue Future Industries to sleep
right-arrow Created with Sketch.
TLG Talga expands Prospectus Offer to $9M, banks $18.5M overall since end of financial year
right-arrow Created with Sketch.
watchlist Created with Sketch. Add AC8 (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.